<H1>Chapter DOI: 10.1186/s13075-016-1020-3<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>49</td></tr><tr><td>Springer references</td><td>3</td></tr><tr><td>Non Springer references</td><td>46</td></tr><tr><td>BibStructured Count</td><td width="10%">44</td></tr><tr><td>BibUnstructured Count</td><td width="10%">5</td></tr><tr><td>DOI already available in SpringerLink</td><td>38</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>3</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>1</td></tr><tr><td>Valid DOI Enriched</td><td>2</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Pincus T, Callahan LF, Sale WG, et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984;27(8):864&#8211;72.</td><td><a href=http://dx.doi.org/10.1002/art.1780270805>10.1002/art.1780270805</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Mitchell DM, Spitz PW, Young DY, et al. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum. 1986;29(6):706&#8211;14.</td><td><a href=http://dx.doi.org/10.1002/art.1780290602>10.1002/art.1780290602</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Scott DL, Symmons DP, Coulton BL, et al. Long-term outcome of treating rheumatoid arthritis: results after 20&nbsp;years. Lancet. 1987;1(8542):1108&#8211;11.</td><td><a href=http://dx.doi.org/10.1016/S0140-6736(87)91672-2>10.1016/S0140-6736(87)91672-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Isom&#228;ki H. Long-term outcome of rheumatoid arthritis. Scand J Rheumatol Suppl. 1992;95:3&#8211;8.</td><td><a href=http://dx.doi.org/10.3109/03009749209101477>10.3109/03009749209101477</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol Suppl. 1996;44:13&#8211;22.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580&#8211;8.</td><td><a href=http://dx.doi.org/10.1136/ard.2010.138461>10.1136/ard.2010.138461</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Bijlsma JW, Weinblatt ME. Optimal use of methotrexate: the advantages of tight control. Ann Rheum Dis. 2007;66(11):1409&#8211;10.</td><td><a href=http://dx.doi.org/10.1136/ard.2007.076463>10.1136/ard.2007.076463</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Jacobs JW. Optimal use of non-biologic therapy in the treatment of rheumatoid arthritis. Rheumatology. 2012;51(4):iv3&#8211;8.</td><td><a href=http://dx.doi.org/10.1093/rheumatology/kes083>10.1093/rheumatology/kes083</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, FirstPage, Author_FamilyName_1, VolumeID, ArticleTitle, JournalTitle</td><td>CrossRef</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Chen YF, Jobanputra P, Barton P, et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess. 2006;10(42):iii&#8211;iv. xi-xiii, 1-229.</td><td><a href=http://dx.doi.org/10.3310/hta10420>10.3310/hta10420</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibBook</td><td>Donahue KE, Garthehner G, Jonas DE, et al. Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults. Rockville: AHRQ Comparative Effectiveness Reviews; 2007.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Singh JA, Christensen R, Wells GA, et al. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ. 2009;181(11):787&#8211;96.</td><td><a href=http://dx.doi.org/10.1503/cmaj.091391>10.1503/cmaj.091391</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Hazes JM, Luime JJ. The epidemiology of early inflammatory arthritis. Nat Rev Rheumatol. 2011;7(7):381&#8211;90.</td><td><a href=http://dx.doi.org/10.1038/nrrheum.2011.78>10.1038/nrrheum.2011.78</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibBook</td><td>Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford: Oxford University Press; 2005.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1136/jech.41.4.355-a>10.1136/jech.41.4.355-a</a></td><td><b>CrossRef-Web</b></td>
<td>BookTitle</td><td>CrossRef</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Buisman LR, Rutten-van M&#246;lken MPMH, Postmus D, et al. The early bird catches the worm: early cost-effectiveness analysis of new medical tests. Int J Technol Assess Health Care. 2016;32(1):1&#8211;8. doi: 10.1017/S0266462316000064.</td><td><a href=http://dx.doi.org/10.1017/S0266462316000064>10.1017/S0266462316000064</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>IJzerman MJ, Steuten LM. Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Appl Health Econ Health Policy. 2011;9(5):331&#8211;47.</td><td><a href=http://dx.doi.org/10.2165/11593380-000000000-00000>10.2165/11593380-000000000-00000</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>The</span> <span style='background:#DDDDDD'>Center for Translational Molecular Medicine</span></span></aug>. <span style='background:#FFD9B3'>Full article on project TRACER</span>. <span style='background:#FF3300'>http://www.ctmm.nl/en/downloads/full-article-downloads-pdf/full-article-on-project-tracer</span>. Accessed 27 Jan <span style='background:#66FF66'>2015</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Van Baarsen LG, Bos WH, Rustenburg F, et al. Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis. Arthritis Rheum. 2010;62(3):694&#8211;704.</td><td><a href=http://dx.doi.org/10.1002/art.27294>10.1002/art.27294</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Gottenberg JE, Dayer JM, Lukas C, et al. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis. 2012;71(7):1243&#8211;8.</td><td><a href=http://dx.doi.org/10.1136/annrheumdis-2011-200975>10.1136/annrheumdis-2011-200975</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Duer-Jensen A, H&#248;rslev-Petersen K, Hetland ML, et al. Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis Rheum. 2011;63(8):2192&#8211;202.</td><td><a href=http://dx.doi.org/10.1002/art.30396>10.1002/art.30396</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Bird P, Conaghan P, Ejbjerg B, et al. The development of the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis. 2005;64(1):i8&#8211;10.</td><td><a href=http://dx.doi.org/10.1136/ard.2004.031807>10.1136/ard.2004.031807</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Nieuwenhuis WP, Krabben A, Stomp W, et al. Evaluation of magnetic resonance imaging-detected tenosynovitis in the hand and wrist in early arthritis. Arthritis Rheumatol. 2015;67(4):869&#8211;76.</td><td><a href=http://dx.doi.org/10.1002/art.39000>10.1002/art.39000</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Sugimoto H, Takeda A, Hyodoh K. Early-stage rheumatoid arthritis: prospective study of the effectiveness of MR imaging for diagnosis. Radiology. 2000;216(2):569&#8211;75.</td><td><a href=http://dx.doi.org/10.1148/radiology.216.2.r00au20569>10.1148/radiology.216.2.r00au20569</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Narv&#225;ez J, Sirvent E, Narv&#225;ez JA, et al. Usefulness of magnetic resonance imaging of the hand versus anticyclic citrullinated peptide antibody testing to confirm the diagnosis of clinically suspected early rheumatoid arthritis in the absence of rheumatoid factor and radiographic erosions. Semin Arthritis Rheum. 2008;38(2):101&#8211;9.</td><td><a href=http://dx.doi.org/10.1016/j.semarthrit.2007.10.012>10.1016/j.semarthrit.2007.10.012</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Machado PM, Koevoets R, Bombardier C, van der Heijde DM. The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: a systematic review. J Rheumatol Suppl. 2011;87:31&#8211;7.</td><td><a href=http://dx.doi.org/10.3899/jrheum.101072>10.3899/jrheum.101072</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Yarwood</span> <span style='background:#DDDDDD'>A</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Huizinga</span> <span style='background:#DDDDDD'>TW</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Worthington</span> <span style='background:#DDDDDD'>J.</span></span></aug> <span style='background:#CCCCFF'>The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA</span>. <span style='background:#CCFF99'>Rheumatology (Oxford)</span>. <span style='background:#66FF66'>2016</span>;<span style='background:#FFCC66'>55</span>(<span style='background:#C8BE84'>2</span>):<span style='background:#D279FF'>199&#8211;209</span>.</td><td><a href=http://dx.doi.org/10.1093/rheumatology/keu323>10.1093/rheumatology/keu323</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, JournalTitle, VolumeID, IssueID, Author_FamilyName_1, FirstPage</td><td>CrossRef</td></tr><tr><td>CR26</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>Dutch Healthcare Authority (Nederlandse Zorgauthoriteit, NZa)</span>. <span style='background:#FFD9B3'>NZa Zorgproducten Tariefapplicatie</span>. <span style='background:#FF3300'>http://dbc-zorgproducten-tarieven.nza.nl/nzaZpTarief/ZoekfunctieDbc.aspx</span>. Accessed 1 May <span style='background:#66FF66'>2013</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Smolen JS, Breedveld FC, Burmester GR, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2015. doi: 10.1136/annrheumdis-2015-207524.</td><td><a href=http://dx.doi.org/10.1136/annrheumdis-2015-207524>10.1136/annrheumdis-2015-207524</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibBook</td><td>Dutch Institute for Healthcare Improvement CBO. Guideline diagnostics and treatment for rheumatoid arthritis (Richtlijn Diagnostiek en behandeling van reumato&#239;de artritis). Utrecht: Dutch Institute for Healthcare Improvement CBO; 2008.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Alves C, Luime JJ, Van Zeben D, et al. Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH). Ann Rheum Dis. 2011;70(9):1645&#8211;7.</td><td><a href=http://dx.doi.org/10.1136/ard.2010.142299>10.1136/ard.2010.142299</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Van Gestel AM, Haagsma CJ, Van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum. 1998;41(10):1845&#8211;50.</td><td><a href=http://dx.doi.org/10.1002/1529-0131(199810)41:10&lt;1845::AID-ART17&gt;3.3.CO;2-B>10.1002/1529-0131(199810)41:10&lt;1845::AID-ART17&gt;3.3.CO;2-B</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology. 2004;43(10):1252&#8211;5.</td><td><a href=http://dx.doi.org/10.1093/rheumatology/keh297>10.1093/rheumatology/keh297</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Prevoo ML, v 't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44&#8211;8.</td><td><a href=http://dx.doi.org/10.1002/art.1780380107>10.1002/art.1780380107</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Luime JJ, Buisman LR, Oppe M, et al. A cost-effectiveness model for evaluating new diagnostic tests in the work-up of patients with inflammatory arthritis at risk of having Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2015. doi: 10.1002/acr.22776.</td><td><a href=http://dx.doi.org/10.1002/acr.22776>10.1002/acr.22776</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>De Jong PH, Hazes JM, Han HK, et al. Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial. Ann Rheum Dis. 2014;73(7):1331&#8211;9.</td><td><a href=http://dx.doi.org/10.1136/annrheumdis-2013-204788>10.1136/annrheumdis-2013-204788</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Claessen SJ, Hazes JM, Huisman MA, et al. Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial. BMC Musculoskelet Disord. 2009;10:71.</td><td><a href=http://dx.doi.org/10.1186/1471-2474-10-71>10.1186/1471-2474-10-71</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Vermeer M, Kievit W, Kuper HH, et al. Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry. BMC Musculoskelet Disord. 2013;14:350.</td><td><a href=http://dx.doi.org/10.1186/1471-2474-14-350>10.1186/1471-2474-14-350</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Tan SS, Bouwmans CA, Rutten FF, et al. Update of the Dutch Manual for Costing in Economic Evaluations. Int J Technol Assess Health Care. 2012;28(2):152&#8211;8.</td><td><a href=http://dx.doi.org/10.1017/S0266462312000062>10.1017/S0266462312000062</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>National Health Care Institute</span>. <span style='background:#FF3300'>http://www.medicijnkosten.nl/default.asp</span>. Accessed 2 Feb <span style='background:#66FF66'>2015</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR39</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>Statistics Netherlands</span>. <span style='background:#FF3300'>http://statline.cbs.nl</span>. Accessed 2 Feb <span style='background:#66FF66'>2015</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Pliskin JS, Shepard D, Weinstein MC. Utility functions for life years and health status. Operations Res. 1980;28(1):206&#8211;24.</td><td><a href=http://dx.doi.org/10.1287/opre.28.1.206>10.1287/opre.28.1.206</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Buitinga L, Braakman-Jansen LM, Taal E, et al. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry. Arthritis Care Res. 2012;64(6):826&#8211;32.</td><td><a href=http://dx.doi.org/10.1002/acr.21619>10.1002/acr.21619</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Lillegraven S, Kristiansen IS, Kvien TK. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69(10):1762&#8211;7.</td><td><a href=http://dx.doi.org/10.1136/ard.2009.124099>10.1136/ard.2009.124099</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Linde L, S&#248;rensen J, &#216;stergaard M, et al. Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1&nbsp;year of biological therapy: a prospective study in clinical practice. J Rheumatol. 2013;40(9):1479&#8211;86.</td><td><a href=http://dx.doi.org/10.3899/jrheum.121387>10.3899/jrheum.121387</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR44</td><td>BibArticle</td><td>S&#248;rensen J, Linde L, Ostergaard M, et al. Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D. Value Health. 2012;15(2):334&#8211;9.</td><td><a href=http://dx.doi.org/10.1016/j.jval.2011.09.010>10.1016/j.jval.2011.09.010</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Verstappen SM, McCoy MJ, Roberts C, et al. Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial. Ann Rheum Dis. 2010;69(3):503&#8211;9.</td><td><a href=http://dx.doi.org/10.1136/ard.2009.119149>10.1136/ard.2009.119149</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Girling A, Young T, Brown C, et al. Early-stage valuation of medical devices: the role of developmental uncertainty. Value Health. 2010;13(5):585&#8211;91.</td><td><a href=http://dx.doi.org/10.1111/j.1524-4733.2010.00726.x>10.1111/j.1524-4733.2010.00726.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Cosh E, Girling A, Lilford R, et al. Investing in new medical technologies: a decision framework. J Commerc Biotechnol. 2007;13(4):263&#8211;71.</td><td><a href=http://dx.doi.org/10.1057/palgrave.jcb.3050062>10.1057/palgrave.jcb.3050062</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR48</td><td>BibBook</td><td>College voor zorgverzekeringen (CVZ). Guidelines for pharmacoeconomic research, updated version. Diemen: College voor zorgverzekeringen; 2006.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Toledano E, Candelas G, Rosales Z, et al. A meta-analysis of mortality in rheumatic diseases. Reumatol Clin. 2012;8(6):334&#8211;41.</td><td><a href=http://dx.doi.org/10.1016/j.reuma.2012.05.006>10.1016/j.reuma.2012.05.006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>